Vontobel Holding Ltd. - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 118 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.

Quarter-by-quarter ownership
Vontobel Holding Ltd. ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$1,038,837
-13.1%
40,659
-2.5%
0.01%0.0%
Q2 2023$1,195,985
-12.7%
41,701
-27.1%
0.01%
-25.0%
Q1 2023$1,370,341
+22.7%
57,169
-13.2%
0.01%
-27.3%
Q4 2022$1,116,952
+3.4%
65,858
-9.6%
0.01%
-15.4%
Q3 2022$1,080,000
-10.7%
72,852
-5.2%
0.01%0.0%
Q2 2022$1,209,000
+16.5%
76,810
+99.5%
0.01%
+44.4%
Q1 2022$1,038,000
-29.9%
38,503
-3.8%
0.01%
-25.0%
Q4 2021$1,481,000
-22.8%
40,018
-0.4%
0.01%
-29.4%
Q3 2021$1,919,000
+44.8%
40,167
+2.6%
0.02%
+54.5%
Q2 2021$1,325,00039,1520.01%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2022
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 456,390$5,541,0003.62%
DAFNA Capital Management LLC 173,914$1,890,0000.65%
One68 Global Capital, LLC 19,861$216,0000.47%
Diametric Capital, LP 51,982$565,0000.41%
ARK Investment Management 1,383,756$15,041,0000.38%
EAM Investors, LLC 52,833$574,0000.13%
HIGHLINE CAPITAL MANAGEMENT, L.P. 31,404$341,0000.05%
Nikko Asset Management Americas, Inc. 280,548$3,050,0000.05%
MGO ONE SEVEN LLC 14,900$161,0000.04%
Qube Research & Technologies Ltd 67,702$736,0000.02%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders